New stents for SFA

Journal of Cardiovascular Surgery

Volumn 50, Issue 5, 2009, Pages 635-645

  Minar, E ^a   Schillinger, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Drug eluting stents; Endovascular surgical procedures; Femoral artery; Stents

Indexed keywords

NITINOL; PACLITAXEL; PLACEBO; STAINLESS STEEL;

ARTERY DISEASE; BIODEGRADABLE IMPLANT; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; FEMOROPOPLITEAL BYPASS; HUMAN; IMPLANTATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSTHESIS FAILURE; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; REVIEW; STENT; STRESS; SUPERFICIAL FEMORAL ARTERY;

AGED; ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; FEMORAL ARTERY; HUMANS; MALE; POPLITEAL ARTERY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RECURRENCE; STENTS; TREATMENT OUTCOME;

EID: 70949089245     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Rogers JH, Laird JR. Overview of New Technologies for Lower Extremity Revascularization. Circulation 2007;116:2072-2085 (Pubitemid 350027514)
2. Schillinger M, Exner M, Mlekusch W, Haumer M, Ahmadi R, Rumpold H et al. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology 2002;224:529-535 (Pubitemid 34809137)
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 (Suppl 1):S5-S67.
4. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-771
5. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlböck M et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000;102:2694-2699.
6. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83:170-180
7. Klein AJ, Chen SJ, Messenger JC, Hansgen AR, Plomondon ME , Carroll JD et al. Quantitative assessment of the conformational change in the femoropopliteal artery with leg movement. Catheter Cardiovasc Interv. 2009 May 7. [Epub ahead of print].
8. Nikanorov A, Smouse HB, Osman K, Bialas M, Shrivastava S, Schwartz LB. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg 2008;48:435-440
9. Choi G, Cheng CP, Wilson NM, Taylor CA. Methods for quantifying three-dimensional deformation of arteries due to pulsatile and nonpulsatile forces: implications for the design of stents and stent grafts. Ann Biomed Engl 2009;37:14-33.
10. Cheng CP, Wilson NM, Hallett RL, Herfkens RJ, Taylor CA. In vivo MR angiographic quantification of axial and twisting deformations of the superficial femoral artery resulting from maximum hip and knee flexion. J Vasc Interv Radiol 2006;17:979-987
11. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-months results. Circulation 2002;106:1505-1509 (Pubitemid 35050878)
12. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty vs. Implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888 (Pubitemid 43872689)
13. Scheinen D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-315 (Pubitemid 40094743)
14. Bosiers M, Torsello G, Gissler HM, Ruef J, Müller-Hülsbeck St, Jahnke Th, Peeters P. Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the DURABILITY I Study. J Endovasc Ther 2009;16:261-269
15. Iida O, Nanto S, Uematsu M, Morozumi T, Kotani J, Awata M et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol 2006;98:272-274
16. Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 2008;36:339-345
17. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E et al. Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 2005;12:676-684
18. Cejna M, Thurnher SA, Illiasch H Cejna M, Thurnher S, Illiasch H et al. PTA vs Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomised study. J Vasc Interven Radiol 2001;12:23-31. (Pubitemid 32097991)
19. Vroegineweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-425
20. Grimm J, Muller-Hulsbeck S, Jahnke T, Hubert C, Brossmann J, Heller M. Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Intervent Radiol 2001;12:935-942
21. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thórne J et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 1999;18:251-255 (Pubitemid 30153799)
22. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomised study. J Vasc Surg 2003;37:487-494 (Pubitemid 36350887)
23. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
24. Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 2001;221:137-145 (Pubitemid 32880382)
25. Kasapis C, Henke P, Chetcuti St, Koenig G, Rectenwald J, Krishnamurthy V et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2009;30:44-55.
26. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G; VIVA Physicians. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 2007;69:910-919
27. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R et al. Patency of nitinol vs. Wallstents in the superficial femoral artery - a propensity score adjusted analysis. Radiology 2004;232:516-521
28. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O et al. Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting. Circulation 2007;115:2745-2749 (Pubitemid 46842791)
29. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL et al. Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length. The Femoral Artery Stenting Trial (FAST) Circulation 2007;116:285-292
30. Ansel GM, Silver MJ, Botti CF Jr, Rocha-Singh K, Bates MC, Rosenfield K et al. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial. Catheter Cardiovasc Interv 2006;67:288-297 (Pubitemid 43235166)
31. Zeller T, Tiefenbacher C, Steinkamp HJ, Langhoff R, Wittenberg G, Schlüter M et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther 2008;15:390-398
32. Ruef J. One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery. Angiology 2009;60:31-35
33. Ferreira M, Lanziotti L, Monteiro M, Abuhadba G, Capotorto LF, Nolte L et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 2007;34:702-708 (Pubitemid 350056379)
34. Mühlenbruch G, Brock H, Das M, Hohl C, Mahnken AH, Wildberger J et al. Initial and mid-term results of a 4F compatible self-expanding low strut profile nitinol stent in the superficial femoral artery. Röfo 2007;179:733-738
35. Lenti M, Cieri E, De Rango P, Pozzilli P, Coscarella C, Bertoglio C et al. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J Vasc Surg 2007;45:32-39 (Pubitemid 46038649)
36. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs. prosthetic femoropopliteal bypass in the treatment of superficial femoral occlusive disease. J Vasc Surg 2007;45:10-16 (Pubitemid 46038657)
37. McQuade K, Gable D, Hohman S, Pearl G, Theune B. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009;49:109-115
38. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008;19:823-832
39. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-710 (Pubitemid 44907633)
40. Brown DA, Lee EW, Loh CT, Kee ST. A new wave in treatment of vascular occlusive disease: biodegradable stents-clinical experience and scientific principles. J Vasc Interv Radiol 2009 ;20:315-324
41. Schillinger M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Minar E. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther 2003; 10:288-297p (Pubitemid 36988602)